Max Planck Innovation is responsible for technology transfer from the research institutes of the Max Planck Society, Germany's leading basic research organization.
We are partners of both science and industry:
- We advise and support scientists at Max Planck Institutes in evaluating their inventions and filing patents.
- We mediate the transfer of inventions from Max Planck Institutes to industry.
- We support scientists at Max Planck Institutes in founding companies.
We perform an important task: the transfer of basic research results into products, which contribute to the economic and social progress.
Anti-mouse and anti-rabbit IgG secondary VHH single domain antibodies optimized for all immuno-labeling applications
Our technologies are as varied as the Max Planck Institutes themselves
all Technology offers
Max Planck Society grants license for protein analysis technique
ProteoPlex has exclusively licensed a technology from the Max Planck Institute for Biophysical ...
Do you want to receive our newsletter and press releases?